Aspirin Versus Low-Molecular-Weight Heparin After Total Hip Arthroplasty

被引：0
|
作者：
Granziera, Serena [1 ]
Cohen, Alexander T. [2 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Kings Coll Hosp London, London, England
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 159卷 / 07期
关键词：
PROPHYLAXIS; TRIAL;
D O I：
10.7326/00030003-4819-159-7-201310010-00017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：502 / 502
页数：1
相关论文
共 50 条
  • [1] Thrombosis Prevention After Total Hip Arthroplasty A Prospective, Randomized Trial Comparing a Mobile Compression Device with Low-Molecular-Weight Heparin
    Colwell, Clifford W., Jr.
    Froimson, Mark I.
    Mont, Michael A.
    Ritter, Merrill A.
    Trousdale, Robert T.
    Buchler, Knute C.
    Spitzer, Andrew
    Donaldson, Thomas K.
    Padgett, Douglas E.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2010, 92A (03) : 527 - 535
  • [2] Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty
    Asopa, Vipin
    Cobain, William
    Martin, David
    Keene, Greg
    Bauze, Adrian
    ANZ JOURNAL OF SURGERY, 2015, 85 (09) : 652 - 657
  • [3] Comparison of low molecular weight heparin, aspirin, and their combination for the prevention of thrombosis after total knee arthroplasty in obese patients
    Mirahmadi, Alireza
    Hosseini-Monfared, Pooya
    Ghane, Shahrzad
    Mortazavi, Mohammad
    Abrishami, Ramin
    Hooshangi, Mohammad Hossein
    Shameli, Vahid
    Kazemi, Seyed Morteza
    JOURNAL OF EXPERIMENTAL ORTHOPAEDICS, 2025, 12 (01)
  • [4] Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?
    Parvizi, Javad
    DeMik, David E.
    Hozack, William J.
    Dunbar, Michael J.
    Mont, Michael A.
    Lachiewicz, Paul F.
    JOURNAL OF ARTHROPLASTY, 2023, 38 (01) : 1 - 2
  • [5] Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?
    Parvizi, Javad
    DeMik, David E.
    Dunbar, Michael
    Hozack, William J.
    Mont, Michael A.
    Lachiewicz, Paul F.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2022, 104 (23) : 2045 - 2046
  • [6] COMPONENTS OF COAGULATION AND FIBRINOLYSIS DURING THROMBOSIS PROPHYLAXIS WITH A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS DEXTRAN-70 IN HIP-ARTHROPLASTY
    BORRIS, LC
    SORENSEN, JV
    LASSEN, MR
    WALENGA, JM
    FAREED, J
    JORGENSEN, LN
    HAUCH, O
    WILLEJORGENSEN, P
    THROMBOSIS RESEARCH, 1991, 63 (01) : 21 - 28
  • [7] Aspirin and Compression Devices Versus Low-Molecular-Weight Heparin and PCD for VTE Prophylaxis in Orthopedic Oncology Patients
    Patel, Anay R.
    Crist, Martha K.
    Nemitz, Jason
    Mayerson, Joel L.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (03) : 276 - 281
  • [8] Chemoprophylaxis for the Hip Fracture Patient: A Comparison of Warfarin and Low-Molecular-Weight Heparin
    Trivedi, Nikunj N.
    Sivasundaram, Lakshmanan
    Wang, Christopher
    Kim, Chang Y.
    Buser, Zorica
    Wang, Jeffrey C.
    Ochenjele, George
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2019, 33 (05) : 216 - 219
  • [9] The Role of Aspirin and Unfractionated Heparin Combination Therapy Immediately After Total Hip and Knee Arthroplasty
    Sobh, Ali H.
    Koueiter, Denise M.
    Mells, Anthony
    Siljander, Matthew P.
    Karadsheh, Mark S.
    ORTHOPEDICS, 2018, 41 (03) : 171 - 176
  • [10] Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
    Xia, Hui
    Wang, Ziyao
    Tian, Min
    Liu, Zunjing
    Zhou, Zhenhua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345